Healthcare VC with $900M+ under management across 7 funds.
Investors
Grants and funding programsTriangle-based investors and outside funds backing companies here.
140 investors· sorted within each section
Triangle based
Local funds, angels, university capital, and programs.
Durham pre-seed and seed fund for North Carolina software startups, founded in 2023 by Joe Colopy and Jenn Summe and part of Colopy Ventures alongside Jurassic Capital and GrepBeat. Structured as an AngelList rolling fund open to outside angels since December 2023. Targets companies with a product in market and paying customers, plans 50 to 60 investments over the life of the fund, and reserves about 70% of its capital for follow-ons in its top-quartile companies.
Venture arm of Duke University, investing in Duke-connected companies from offices in Durham. The portfolio spans consumer, enterprise, and life science nationally; Triangle holdings include Tune Therapeutics, restor3d, Pryon, Teamworks, and Vulcan Elements.
Grant and investment vehicle for NC startups.
Seed stage B2B software in the Southeast. 43+ investments.
Duke Innovation & Entrepreneurship program
B2B software VC. 39 portfolio companies.
Angel network connecting NC State alumni investors with NC State-affiliated startups, run out of the university's Office of Research and Innovation. Members have invested more than $20M since the network's 2016 founding.
Angel network for the UNC-Chapel Hill community, pairing alumni investors with university-connected startups alongside the Carolina Growth Fund co-investment vehicle.
Family office ("Second Foundation") founded by Bill Spruill after the roughly $300M sale of Global Data Consortium to the London Stock Exchange Group in 2022, run by a five-person full-time team from Raleigh. Its stated focus is founder wealth creation on two tracks: deep-tech and big-tech founders in the RTP region, and people-of-color technology founders nationwide, combining for-profit investing with philanthropic programs. Programs include founder education on equity preservation, investor matchmaking, and the Minority Achievers Initiative, a national cohort of big-tech and deep-tech founders run with American Underground (first cohorts October 2024 and January 2025). Spruill's angel record includes DocFox (sold to nCino), Union Metrics (sold to TrendKite/Cision), Magnus Health (private-equity acquisition), and Loqate (acquired by GB Group), with more than 80 companies mentored; he serves on the boards of CED and Triangle Family Services and as a Non-Executive Director of nCino.
Durham growth-equity fund for B2B software companies in underserved regions, founded by Joe Colopy and Kevin Mosley and part of Colopy Ventures alongside Primordial Ventures and GrepBeat. Fund I closed oversubscribed at $30M (January 2022 vintage). Writes $1.5M to $3M initial checks for large minority stakes in companies at $2M to $6M ARR, and publishes an annual B2B SaaS benchmarks report.
Strategy and Corporate Development Consultant | Board Member | Investor | Advisor. 25 years of experience, ~$7B in cumulative deal value. Triangle-based individual investor and board/advisor across multiple local software companies. Per-company roles: Scale Social AI — investor (Oct 2025) and advisor; Bull City Venture Partners — investor and advisory board member; Levitate — board member.
Raleigh early-stage venture firm investing in physical and industrial technology across the Southeast, founded 2018. Typical checks run $500K to $1.5M from pre-seed through Series A. OPC Opportunity Fund I LP filed a Form D on 2025-01-15 recording $9,660,000 sold against a $20,000,000 offering, with Justin Wright-Eakes as a related person.
Individual investor who has run a private family office in the Triangle since 2015 and, by his own account, backed one Morrisville drug-development team across three companies: seed positions in Neuronex (2011) and Aerial BioPharma (2011) and a Series A position with an advisory board seat at Arrivo BioVentures (2016). Investor and board member at Betr Health (Raleigh) since 2015. Also founder and CEO of Pinnacle Hospitality Partners, a Triangle hotel management and development company, and a limited partner in Frist Cressey Ventures (chair of the LP committee for Funds II and III) and HCG Digital Ventures. Positions are self-reported on his public LinkedIn profile as supplied by Adam on 2026-09-18; Arrivo's releases confirm private investors participated in both rounds without naming them.
Individual angel investor, distinct from his family office 2ndF, which has its own row. Founder of Global Data Consortium (sold to the London Stock Exchange Group in 2022 for roughly $300M). His personal angel record per GrepBeat (2025-04-15) includes DocFox (sold to nCino), Union Metrics (sold to TrendKite/Cision), Magnus Health (private-equity acquisition) and Loqate (acquired by GB Group), with more than 80 companies mentored. Named personally, alongside Tweener Fund and Scot Wingo, as an investor in Flytes (Cary) per the company's Wefunder page as recorded in its directory enrichment note. Serves on the boards of CED and Triangle Family Services and as a non-executive director of nCino.
Cary early-stage investment group backing medical technology, industrial technology, clean or green technology, and B2B SaaS companies. Harbright Ventures led SonoVascular's $6M Series A first close in 2026.
Early-stage VC focused on digital disruption. 62+ companies.
Angel network in the Research Triangle Park region focused on seed and early-stage, technology-centric companies near revenue.
Individual angel investor, distinct from the NC Tweener Fund, where he has been a general partner since January 2022 and which has its own row. Four-exit Triangle founder: Stingray Software (acquired by Rogue Wave, 1999), ChannelAdvisor (founder and CEO from 2001 to 2015 through its 2013 IPO, board member to 2022), Spiffy (co-founder and CEO, 2017 to 2024), and now co-founder and CEO of ReFiBuy.ai (2025). Named personally, alongside Tweener Fund and Bill Spruill, as an investor in Flytes (Cary) on the company's Wefunder page, which lists the fund and the individual separately. NC State alumnus (Master of Computer Engineering).
BDIP
Venture fund · Raleigh, NC
0companies
BDIP Fund II, L.P. filed a Form D on 2025-04-24 recording $159,476,621 sold from 4350 Lassiter at North Hills Avenue, Raleigh; related persons include Adam Daigle and Chris Burnham.
Bullhouse
Pre-seed (Angel + SPV) · Durham, NC
0companies
Founder-led pre-seed partnership in Downtown Durham. $5K angel checks plus deal-by-deal SPVs up to $100K. Post-product, often first check in.
Conductor Capital
Venture fund · Durham, NC
0companies
Filed a Form D on 2025-06-02 recording $42,181,818 sold against a matching offering from 321 E Chapel Hill Street, Durham; related persons include Dhruv Patel and John Mansfield.
Dental Innovation Alliance
Venture fund · Cary, NC
0companies
Sector-focused venture fund. Dental Innovation Alliance VC Fund I, LP filed a Form D on 2025-04-30 recording $26,225,000 sold from a Cary address; related persons include Thomas Sharpe and Mark Friedman.
Duke Innovation & Entrepreneurship
University fund · Durham, NC
0companies
Echo Health Ventures
Venture fund · Durham, NC
0companies
Healthcare venture firm. Echo Innovation Alliance LLC filed a Form D on 2026-01-21 recording $207,361,038 sold from a Durham address.
First Flight Venture Center
Accelerator · RTP, NC
0companies
102-company portfolio. 4 IPOs, 13 acquisitions.
Pappas Capital
Venture fund · Durham, NC
0companies
Durham venture capital and commercial development firm focused on life-science, agriculture, and technology companies. The firm operates Pappas Ventures, Specialized Fund Management, and Translational Medicine; Pappas Ventures reports six funds raised, 40 IPO or M&A transactions across the portfolio, four companies sold for $1B or more, and 27 approved products developed by portfolio companies.
Person Street Partners
Venture fund · Cary, NC
0companies
Person Street Partners GP Fund I, L.P. filed a Form D on 2025-09-11 recording $9,800,000 sold against a $20,000,000 offering from 4000 Centregreen Way, Cary; related persons include Jacob Jatis and Poojan Mehta.
Plexus Capital
Venture fund · Raleigh, NC
0companies
Lower-middle-market investment firm. Plexus Fund VII-A, L.P. filed a Form D on 2025-05-14 recording $102,000,000 sold from 4242 Six Forks Road, Raleigh.
Prudent Growth Partners
Venture fund · Chapel Hill, NC
0companies
Small-business acquisition investment firm. Prudent Growth Fund III, LLC filed a Form D on 2026-03-24 recording $23,825,000 sold against an $80,000,000 offering from 141 Providence Road, Chapel Hill.
QHP Capital
Venture fund · Raleigh, NC
0companies
Healthcare and life-sciences investment firm. Filed Form Ds for QHP Private Equity Fund III-A ($262,231,000) and III-B ($172,850,000) on 2025-12-18 from a Raleigh address; related persons include Vern Davenport, Ashton Poole, and Ryan Applegate.
Outside the Triangle
Investors elsewhere with tracked Triangle company connections.
NC Tweener Fund
Rolling Fund · Statewide, NC
76companies
Index fund for NC startups
UNC Health Ventures
Corporate investor · Morrisville, NC
5companies
Corporate venture fund of the UNC Health system, established in 2012 as Rex Health Ventures with about $10 million and a Triangle focus, and renamed UNC Health Ventures on 2026-08-18 with $125 million to invest over the next decade from reallocated capital reserves. Invests primarily at Series A and Series B across medtech, healthtech, and biotech, is geographically agnostic, and has backed 30 companies with 12 active as of the rebrand. Anita Watkins and John Perez are managing directors. Active Triangle holdings include 410 Medical, baebies, Phononic, and Pryon; Emergo Therapeutics is a prior investment.
Cape Fear BioCapital
Venture fund · NC
4companies
Seed-stage therapeutics fund launched 2024.
RA Capital Management
Venture fund · Boston, MA
3companies
RA Capital Management, L.P. is a Boston-based healthcare and life-sciences crossover investor, founded in 2004 by Vertex co-founder Richard Aldrich, investing across private and public markets. It leads seed and venture rounds, anchors IPOs, and provides follow-on public-market and structured capital. A separate Planetary Health Fund backs climate, minerals, energy, and agriculture companies with near-term commercialization paths. RA Capital pairs capital with in-house company-building teams, including its TechAtlas landscape-mapping engine, the Blackbird clinical-development accelerator, and the Raven biotech incubator. Reported scale: more than 250 employees and over $14B in assets under management. Locally, RA Capital co-led Slate Medicines' $130M Series A launch and participated in Incyclix Bio's Series B.
Alexandria Venture Investments
Corporate investor · Pasadena, CA
2companies
Strategic venture capital platform of Alexandria Real Estate Equities, investing in life science companies. Investor in IMMvention Therapeutix (Durham) and Hoofprint Biome (Raleigh).
Draper Associates
Venture fund
2companies
Eshelman Ventures
Venture fund
2companies
Knoll Ventures
Venture fund
2companies
Orlando Health Ventures
Corporate investor · Orlando, FL
2companies
S3 Ventures
Venture fund
2companies
Solas BioVentures
Venture fund · Chattanooga, TN
2companies
Life-science venture firm co-founded by physician-investor David Adair, who sits on the Arrivo BioVentures board. Fund I participated in Arrivo's 2016 launch financing and the Emerging Healthcare Fund in its 2023 Series B; the firm also invested in Basking Biosciences' 2023 round. Adair's prior boards include Aerial BioPharma (Morrisville, sold its lead asset to Jazz in 2014).
SOSV
Venture fund
2companies
Venture investor that runs the IndieBio life-science program. Participated in Ten63 Therapeutics' 2023 Series A after the company went through IndieBio's 2019 class.
ABB
Corporate investor
1company
Artis Ventures
Venture fund
1company
Atlanta Seed Company
Venture fund · Atlanta, GA
1company
Black Opal Ventures
Venture fund
1company
Blue Lake VC
Venture fund
1company
Boxer Capital
Venture fund
1company
Chugai Venture Fund
Corporate investor
1company
Commerce Ventures
Venture fund
1company
Corteva Catalyst
Corporate investor
1company
CreativeCo Capital
Venture fund
1company
Delin Ventures
Venture fund · London, UK
1company
Venture firm investing in early-stage life sciences companies. Investor in IMMvention Therapeutix (Durham).
Discovery Innovations
Venture fund
1company
EGB Capital
Venture fund
1company
Eight Roads Ventures
Venture fund
1company
Eli Lilly
Corporate investor
1company
Engine Ventures
Venture fund
1company
Evidenced VC
Venture fund
1company
Fifth Wall
Venture fund
1company
Fine Structure Ventures
Venture fund
1company
First Analysis
Venture fund
1company
First Star Ventures
Venture fund
1company
Flare Capital Partners
Venture fund
1company
Flathead Forge
Venture fund
1company
Flybridge Capital Partners
Venture fund · Boston, MA
1company
Boston-based early-stage venture capital firm, founded 2002. Invests across consumer, enterprise SaaS, and frontier tech.
Forbion
Venture fund
1company
Foresite Capital
Venture fund
1company
Freestyle Capital
Venture fund
1company
Front Porch Venture Partners
Venture fund
1company
Frontier Growth
Venture fund · Charlotte, NC
1company
Growth equity firm for software companies with 5 to 30 million dollars in revenue. Existing ServiceTrade investor as of the 2021 round.
G20 Ventures
Venture fund
1company
Gates Foundation
Venture fund
1company
Gray Ventures
Venture fund · Atlanta, GA
1company
Harbert Growth Partners
Venture fund
1company
Helios Climate Ventures
Venture fund
1company
Incubate Fund
Venture fund
1company
Insight Partners
Venture fund
1company
Intel Capital
Corporate investor
1company
Corporate venture investor. Participated in K4Connect's $21 million Series B announced July 8, 2020.
Jazz Pharmaceuticals
Corporate investor · Dublin, Ireland
1company
Global biopharmaceutical company (Nasdaq: JAZZ) that acquired Aerial BioPharma's narcolepsy asset ADX-N05 in 2014 and led the 2016 launch financing of the same team's next company, Arrivo BioVentures, with a $25 million commitment callable over five years, holding a board observer seat.
JMI Equity
Venture fund · Baltimore, MD and San Diego, CA
1company
Growth equity firm investing in software companies. Led ServiceTrade's 2021 growth round.
Johnson & Johnson Innovation - JJDC
Corporate investor
1company
Jupiter Bioventures
Venture fund
1company
Biotech venture foundry that founds, operates and invests in its own portfolio companies. Co-founded by Norman "Ned" Sharpless, former director of the National Cancer Institute, acting FDA commissioner, and director of UNC Lineberger Comprehensive Cancer Center. Seed investor in Persistence Therapeutics (Chapel Hill).
K-Street Capital
Venture fund
1company
K5 Global
Venture fund
1company
Lookout Ventures
Venture fund
1company
Lux Capital
Venture fund
1company
MCJ
Venture fund
1company
MetaProp
Venture fund
1company
Mitsubishi Heavy Industries
Venture fund
1company
Morpheus Ventures
Venture fund
1company
Venture investor that led Ten63 Therapeutics' round before its 2023 Series A and more than doubled its investment in that Series A.
National Science Foundation
Government program
1company
U.S. federal agency that funds research and Small Business Innovation Research grants.
New Industry VC
Venture fund
1company
NewRoad Capital Partners
Venture fund
1company
North Coast Ventures
Venture fund
1company
Northwestern Mutual Future Ventures
Corporate investor
1company
Osage University Partners
Venture fund · Bala Cynwyd, PA
1company
Venture firm that invests exclusively in startups commercializing university research, in partnership with university technology-transfer offices. Investor in IMMvention Therapeutix (Durham).
Paladin Capital Group
Venture fund
1company
Panorama
Venture fund
1company
Pharmacosmos
Corporate investor
1company
Propel Ventures
Venture fund
1company
PSP Partners
Venture fund
1company
Resilient Ventures
Venture fund
1company
Ridge Ventures
Venture fund
1company
RXR Arden Digital Ventures
Venture fund
1company
RYSE
Venture fund
1company
Sabanci Climate Ventures
Venture fund
1company
Sands Capital
Venture fund
1company
SE Ventures
Corporate investor
1company
SF Holdings
Venture fund
1company
Shell Ventures
Corporate investor
1company
Corporate venture arm of Shell. Joined Extellis' seed round as a new investor in July 2026.
Silicon Road Ventures
Venture fund
1company
Silver Blue
Venture fund
1company
Simpson Strong-Tie
Corporate investor
1company
Spark Capital
Venture fund
1company
Stellaris Venture Partners
Venture fund
1company
Venture capital firm. Backed GTM Buddy in 2021 and participated in its $8 million Series A announced April 9, 2024.
Suffolk Technologies
Corporate investor
1company
Tencent
Corporate investor
1company
TinySeed
Accelerator · Minneapolis, MN
1company
Remote accelerator and fund for bootstrapped B2B SaaS companies. Suggestion Ox is in its fall 2021 cohort, per https://tinyseed.com/latest/fall-2021-batch; the investment amount is undisclosed.
TomEnterprise
Venture fund
1company
Uncorrelated
Venture fund
1company
Valor Ventures
Venture fund
1company
VC 414
Venture fund
1company
Early-stage venture capital fund focused on Midwest and emerging-market startups (Milwaukee-area lineage; the 414 area code).
VELA Partners
Venture fund
1company
Vertex Ventures
Venture fund
1company
Viking Global Investors
Venture fund
1company
VTC Ventures
Venture fund
1company
Wellington Management
Venture fund
1company
Yu Galaxy
Venture fund
1company
ARCH Venture Partners
Venture fund · Chicago, IL; Mercer Island, WA
0companies
ECMC Foundation
Los Angeles, CA
0companies
ECMC Group Education Impact Fund
Corporate investor · Minneapolis, MN
0companies
Lumira Ventures
Venture fund
0companies
Life sciences venture capital firm. Lists G1 Therapeutics in its portfolio; the portfolio page does not identify a specific financing round.
Mission BioCapital
Venture fund
0companies
Life-sciences venture firm. An early investor in Cereius, the Durham Duke spinout Solve Therapeutics acquired in 2023, per general partner Eric Linsley.
NIH
Government program · Bethesda, MD
0companies
Updata Partners
Washington, DC
0companies
Yosemite
Venture fund · San Francisco, CA
0companies